Earnings

UiPath Stock Faces Critical Three-Day Test with Earnings on Deck

UiPath shares closed Friday at $10.93, up 3.41%, ahead of fiscal Q1 results due May 28. The stock is up 6.4% from last week as markets close for Memorial Day.

James Calloway · · 3 min read · 0 views
UiPath Stock Faces Critical Three-Day Test with Earnings on Deck
Mentioned in this article
PATH $10.93 +3.41%

UiPath (PATH) shares enter a holiday-shortened week with momentum, closing Friday at $10.93—a 3.41% gain—as investors prepare for the company's fiscal first-quarter earnings report due after the market close on Thursday, May 28. The stock has risen 6.4% from last Friday's close of $10.27, signaling a tentative rebound from recent lows.

U.S. markets will be largely closed early this week, with the New York Stock Exchange and Nasdaq shut on Monday for Memorial Day. This leaves only three trading sessions—Tuesday through Thursday—for investors to position themselves ahead of UiPath's results. The company will host its earnings call at 5:00 p.m. EDT on Thursday.

Management has guided for first-quarter revenue in the range of $395 million to $400 million, with annual recurring revenue (ARR) projected between $1.894 billion and $1.899 billion for the period ending April 30. Analysts surveyed by Benzinga expect earnings per share of 13 cents on revenue of $397.47 million. The focus will be on whether automation and AI agent demand is translating into stronger subscription growth.

Broader market trends have provided tailwinds. U.S. stocks finished their eighth consecutive winning week on Friday, with the S&P 500 gaining 0.4%, the Dow Jones Industrial Average rising 0.6%, and the Nasdaq Composite adding 0.2%. The Russell 2000 outperformed with a 2.7% weekly gain, suggesting investor interest beyond megacap technology names.

UiPath needs to demonstrate independent strength. In March, the company reported fiscal fourth-quarter revenue of $481 million, a 14% year-over-year increase. ARR reached $1.853 billion, up 11%. The firm completed a $1 billion share buyback and approved a new $500 million repurchase plan. CEO Daniel Dines described the quarter as "strong," while Ashim Gupta, who oversees operations and finance, noted that UiPath achieved GAAP profitability for the full year for the "first time in company history."

Last week, UiPath received a bullish boost when it was named a Leader in Forrester's Q2 2026 report on document mining and analytics platforms. The company's software specializes in extracting data from documents such as invoices and contracts. "Documents are the connective tissue of enterprise processes," said Badri Narayanan, UiPath's senior vice president of software engineering.

The competitive landscape remains intense. Forrester noted that UiPath faces competition from enterprise content specialists like Iron Mountain and OpenText, as well as automation vendors such as Automation Anywhere. UiPath differentiates itself by integrating document processing into its broader agent, orchestration, governance, and human review suite.

Revenue, ARR, and fiscal-year guidance will be the key catalysts this week. UiPath is forecasting fiscal 2027 revenue between $1.754 billion and $1.759 billion, with ARR in the range of $2.051 billion to $2.056 billion. Any adjustments to these forecasts could carry more weight than a first-quarter earnings beat or miss.

Risks remain on both sides. UiPath's most recent annual report highlighted potential headwinds including weaker demand, lower-priced competitors, packaged software alternatives, and faster AI rollouts by rivals. Customers may also question UiPath's outlook if they perceive its technology lagging behind advances in generative and agent AI.

For now, PATH is trading as a rebound story, but uncertainty persists. The stock lifted off its May 14 close of $9.67 and session low of $9.20, but last week's attempt to break above $11.30 failed to hold. Investors sold into strength ahead of results, reflecting hesitation about the company's near-term trajectory.

This article is for informational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Market data may be delayed. Always conduct your own research and consult a licensed financial advisor before making investment decisions.

Related Articles

View All →